Finance

Lists
543828:BOM
Sudarshan Pharma Industries Ltd
36,25 INR
0,00%
(0,00) 1D
16-окт., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 543828...
Open
35,20 INR
High
36,99 INR
Low
35,06 INR
Mkt. cap
9,22 млд
Avg. vol.
409,20 миң
Volume
72,00 миң
P/E ratio
34,94
52-wk high
42,79 INR
52-wk low
18,50 INR
EPS
1,04 INR
No. of employees
64
Open
35,20 INR
High
36,99 INR
Low
35,06 INR
Mkt. cap
9,22 млд
Avg. vol.
409,20 миң
Volume
72,00 миң
P/E ratio
34,94
52-wk high
42,79 INR
52-wk low
18,50 INR
EPS
1,04 INR
No. of employees
64
News stories
From web sources and news partners
About Sudarshan Pharma Industries Ltd
CEO-
Employees64
Founded2008
Headquarters-
SectorSpeciality chemicals
Last report
2026-ж., 12-авг.
Fiscal period
Q1 2027
- / -
Revenue / Est. (INR)
1,74 млд / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
1,69 млд
1,68 млд
2,21 млд
1,74 млд
Cost of goods sold
1,52 млд
1,48 млд
1,90 млд
1,50 млд
Cost of revenue
1,52 млд
1,48 млд
1,90 млд
1,50 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17,78 млн
19,74 млн
33,01 млн
20,68 млн
Operating expense
82,51 млн
102,47 млн
106,15 млн
101,78 млн
Total operating expenses
1,61 млд
1,58 млд
2,01 млд
1,60 млд
Operating income
83,02 млн
99,60 млн
200,65 млн
144,93 млн
Other non operating income
18,63 млн
15,18 млн
-49,24 млн
12,20 млн
EBT including unusual items
42,28 млн
51,98 млн
157,04 млн
75,05 млн
EBT excluding unusual items
42,28 млн
51,98 млн
146,84 млн
75,05 млн
Income tax expense
3,56 млн
10,50 млн
43,12 млн
18,96 млн
Effective tax rate
8,41%
20,20%
27,46%
25,26%
Other operating expenses
55,72 млн
73,62 млн
62,22 млн
67,03 млн
Net income
41,83 млн
43,57 млн
107,26 млн
58,55 млн
Net profit margin
2,48%
2,59%
4,86%
3,36%
Earnings per share
-
-
-
-
Interest and investment income
-
-
20,21 млн
-
Interest expense
-59,38 млн
-62,79 млн
-46,82 млн
-82,07 млн
Net interest expenses
-59,38 млн
-62,79 млн
-26,61 млн
-82,07 млн
Depreciation and amortization charges
9,01 млн
9,11 млн
10,93 млн
14,06 млн
EBITDA
91,95 млн
102,17 млн
206,78 млн
154,40 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору